The overall ratings of 3 Health Care Equipment & Supplies stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Anika Therapeutics, Inc. (ANIK) experiences a ratings drop this week, going from last week’s C to a D. Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. The company also gets F’s in sales growth. For more information, get Portfolio Grader’s complete analysis of ANIK stock.
This week, GenMark Diagnostics, Inc. (GNMK) drops from a C to a D rating. GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of GNMK stock.
This week, Akers Biosciences, Inc.’s (AKER) rating worsens to a D from the company’s C rating a week ago. The company also gets F’s in sales growth, earnings revisions, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of AKER stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.